2026-08-29T14:55:44Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/150042024-09-27T20:05:00Zcom_20.500.12105_2052com_20.500.12105_2051col_20.500.12105_19609

00925njm 22002777a 4500 dc Maurer, Florian P author Shubladze, Natalia author Kalmambetova, Gulmira author Felker, Irina author Kuchukhidze, Giorgi author Drobniewski, Francis author Yedilbayev, Askar author Ehsani, Soudeh author European Laboratory Initiative on TB, HIV and Viral Hepatitis author Avellón, Ana author 2021-06 We assessed the impact of COVID-19 on diagnostic services for tuberculosis (TB) by national reference laboratories in the WHO European Region. Of 35 laboratories, 30 reported declines in TB sample numbers, amounting up to > 50% of the pre-COVID-19 volumes. Sixteen reported reagent or consumable shortages. Nineteen reallocated ressources to SARS-CoV-2 testing, resulting in an overall increase in workload, largely without a concomitant increase in personnel (n = 14). This poses a risk to meeting the 2025 milestones of the End TB Strategy. Euro Surveill. 2021 Jun;26(24):2100426. 10.2807/1560-7917.ES.2021.26.24.2100426 1560-7917 Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 34142651 http://hdl.handle.net/20.500.12105/15004 PCR SARS-CoV-2 Diagnostics Impact of the COVID-19 pandemic on tuberculosis national reference laboratory services in the WHO European Region, March to November 2020